科言猫
学术研究的AI总结
首页
文献互助
订阅
我的收藏
科研工具
选题分析
论文总结
专利管理
专利缴费
专利查询
未登录
返回
期刊详情
D
Drug Testing and Analysis
IF
2.7
论文数
170
被引数
相关解读
0
订阅
期刊论文
170
相关解读
0
期刊论文
170
发表时间
发表时间
IF
被引数
Detection of the Proposed GHB-Pentose Metabolite in Hospital Admission Blood Samples—Response to Faldborg et al.
检测提议的GHB-戊糖代谢物在医院入院血液样本中——对Faldborg等人论文的回应
Drug Testing and Analysis
IF
2.7
2026-10-26
0
PRE
AI
Stephen Trobbiani; Peter Stockham; Chris Kostakis; Sam Alfred; Emma Partridge
分享
收藏
Add a Clinical-Harm Layer to Wastewater and Drug-Checking Triangulation
在废水监测和药物检测三角验证中增加临床危害层级
Drug Testing and Analysis
IF
2.7
2026-10-26
0
PRE
AI
Yun-Han Yang; Lien-Chung Wei
分享
收藏
Retrospective Study on the Power and Interpretation of Chiral Amphetamine Analysis in Hair for Forensic Applications
法医学应用中毛发中手性安非他明分析的功效与解释的回顾性研究
Drug Testing and Analysis
IF
2.7
2026-10-26
0
OA
AI
Liesl K. Janssens; Milena M. Madry; Andrea E. Steuer; Tina M. Binz
分享
收藏
Detection of CJC-1295 in Equine Plasma by ELISA
通过ELISA检测马血浆中的CJC-1295
Drug Testing and Analysis
IF
2.7
2026-10-26
0
PRE
AI
Mark Timms; Adam Cawley; Rohan Steel
分享
收藏
First Occurrence of Fatal Intoxication Involving Methiodone (IC-26) in Finland; a Medicolegal Autopsy Case Report
首次在芬兰报告涉及美他多辛(IC-26)致死中毒的法医尸检病例报告
Drug Testing and Analysis
IF
2.7
2026-10-26
0
OA
AI
Lasse Pakanen; Raimo A. Ketola; Pirkko Kriikku
分享
收藏
Selective Androgen Receptor Modulators (SARMs) in Sport: Patterns of Use, Product Contamination, Health Risks and Doping-Control Implications
运动中的选择性雄激素受体调节剂(SARMs):使用模式、产品污染、健康风险及反兴奋剂控制的启示
Drug Testing and Analysis
IF
2.7
2026-10-24
0
PRE
AI
Jakob Adolf; Georgi Enev
分享
收藏
Analytical Strategies for the Identification and Differentiation of Positional Isomers of
N
‐(2‐Methoxybenzyl)‐2‐(trimethoxyphenyl)ethanamines by Chromatography and Mass Spectrometry
色谱和质谱法鉴定与区分
N
‐(2‐甲氧基苄基)‐2‐(三甲氧基苯基)乙胺的位置异构体分析策略
Drug Testing and Analysis
IF
2.7
2026-10-20
0
PRE
AI
Olga V. Kupriyanova; Vadim A. Shevyrin
分享
收藏
Special Issue on the 29th Meeting of the Society of Hair Testing in London
伦敦第29届毛发检测学会会议专题论文集
Drug Testing and Analysis
IF
2.7
2026-10-18
0
OA
AI
Maristela Andraus
分享
收藏
Pre-Games Anti-Doping Testing for Paris 2024: Operational Challenges and Lessons for Future Major Sporting Events
巴黎2024奥运会赛前反兴奋剂检测:运营挑战及对未来大型体育赛事的启示
Drug Testing and Analysis
IF
2.7
2026-10-13
0
PRE
AI
Manuel Sarmiento-Cruz
分享
收藏
Biomarker Approach for Differentiating Boldenone Administration From Ex Vivo Formation in Colt Urine
区分马驹尿样中宝丹酮给药与体外形成的方法:生物标志物研究
Drug Testing and Analysis
IF
2.7
2026-10-09
0
PRE
AI
Marjaana Viljanto; Florian Bagilet; Pamela Hincks; Jocelyn Habershon‐Butcher; Ludovic Bailly‐Chouriberry; James Scarth
分享
收藏
Population-Stratified Distributions of Post-Mortem Blood Drug Concentrations: An Epidemiological Framework for Contextual Interpretation
基于人群分层分布的死后血液药物浓度:用于情境解释的流行病学框架
Drug Testing and Analysis
IF
2.7
2026-10-07
0
OA
AI
Thikra Algahtani; Kirsten L. Rock; Kathleen Rice-Davies; Rebecca Lo; Benedict Morley; Stephen Morley; Caroline S. Copeland
分享
收藏
Intra‐Individual Variability of Blood and Urinary Steroid Markers and the Response to Codeine Intake in Healthy Men and Women
个体内血液和尿液类固醇标志物的变异及对可待因摄入的反应在健康男性和女性中的研究
Drug Testing and Analysis
IF
2.7
2026-10-07
0
PRE
AI
Alexander Andersson; Basam Yousif; Anton Pohanka; Annica Börjesson; Mikael Lehtihet; Lena Ekström
分享
收藏
Potential Contamination Cases in Anti-Doping: Experiences and Practices of 33 Anti-Doping Organisations
反兴奋剂中的潜在污染案例:33个反兴奋剂组织的经验和实践
Drug Testing and Analysis
IF
2.7
2026-10-07
0
OA
AI
Kristian Slíž; Liene Kozlovska; Fredrik Lauritzen
分享
收藏
Trends in Fentanyl Adulteration From Rapid Drug Analysis and Research (RaDAR) Drug Checking Samples, January 2024 to June 2026
2024年1月至2026年6月快速药物分析与研究(RaDAR)药物检测样本中芬太尼掺假趋势
Drug Testing and Analysis
IF
2.7
2026-10-07
0
PRE
AI
Edward Sisco; Elise M. Pyfrom; Meghan G. Appley; Elizabeth L. Robinson; Katya A. Beltran; Sarah A. Shuda
分享
收藏
Evidence for the Effectiveness of the Performance Passport Within an Intelligence-Based Weightlifting Anti-Doping Programme
基于智能的举重反兴奋剂计划中表现护照有效性的证据
Drug Testing and Analysis
IF
2.7
2026-10-05
0
OA
AI
Gregory Hayward; Jim E. Griffin; Laurentiu C. Hinoveanu; Lorenzo Gaborini; Neil Robinson; James G. Hopker
分享
收藏
Orphaned by an Evidentiary Standard: How Efficacy Review Emptied the Anabolic-Androgenic Steroid Market, and What Doping Control Inherited
被证据标准遗弃:效力审查如何清空了合成代谢-雄性激素类固醇市场,以及兴奋剂控制继承了什么
Drug Testing and Analysis
IF
2.7
2026-10-03
0
PRE
AI
Jakob Adolf; Georgi Raykov
分享
收藏
Detection and Excretion Profiling of Semaglutide Use in Human Urine by UHPLC-HRMS for Anti-Doping Purpose
通过UHPLC-HRMS检测和排泄谱分析人类尿液中的司美格鲁肽使用情况以用于反兴奋剂目的
Drug Testing and Analysis
IF
2.7
2026-10-03
0
PRE
AI
Tian Tian; Xi Chen; Xiaojun Deng
分享
收藏
Estimating Illicit Stimulant Drug Consumption in Luxembourg Using Wastewater-Based Epidemiology
利用污水流行病学估算卢森堡非法兴奋剂药物消费
Drug Testing and Analysis
IF
2.7
2026-10-02
0
OA
AI
Nadine Berndt; Luca Wiltgen; Nicolas Villani; Georges Dahm; Karin Roschel; Serge Schneider
分享
收藏
Forensic Identification and Structural Characterization of ZC-B: A New Azetidine 2C-Series Phenethylamine From Illicit Seized Capsules
ZC-B的司法鉴定与结构表征:一种来自非法扣押胶囊的新型氮杂环丁烷2C系列苯乙胺
Drug Testing and Analysis
IF
2.7
2026-10-02
0
PRE
AI
Hong Song; Luyi Zeng; Li Wu; Haixing Wang; Chao Yuan; Hongjian Zhang; Jianhong Gao
分享
收藏
Impact of Drone Versus Car Transport on Anti-Doping Sample Integrity Over Short Distances: A Proof-Of-Concept Study
无人机与汽车运输对短距离反兴奋剂样品完整性的影响:一项概念验证研究
Drug Testing and Analysis
IF
2.7
2026-09-29
0
OA
AI
I. Al-Mohannadi; M. Y. Al-Jaber; M. Al-Nesf; W. Samsam; Abdulaziz Farooq; N. M. Thomas; M. Stuart; N. Robinson; G. Zangenfeind; D. Rovira; N. Mohamed-Ali; A. Beotra; V. Mohamed-Ali; M. Al-Maadheed
分享
收藏